Strolll rolls out neurorehabilitation at Northumbria NHS Foundation Trust

IW Capital’s portfolio company, Strolll, is advancing neurological rehabilitation through augmented reality–powered prescription digital therapeutics. Building on its impressive list of clients in the UK and US, it recently rolled its platform out at Northumbria Healthcare NHS Foundation Trust. The Trust is now fully equipped and trained to use Strolll’s technology across its neurological physiotherapy services. This marks a significant step forward in the delivery of rehabilitation for patients with complex neurological conditions. 

Strolll’s platform represents a shift in how rehabilitation is experienced by people living with conditions such as Parkinson’s disease, stroke and multiple sclerosis. Conventional physiotherapy exercises can feel repetitive and, for many patients, difficult to sustain over time. Strolll addresses this by converting these exercises into immersive therapeutic activities that encourage participation and maintain motivation throughout the rehabilitation process. 

The platform also enables home-based neurorehabilitation, giving patients greater flexibility and control over their therapy. This increased autonomy can improve adherence, reduce fatigue and create a more personalised and encouraging recovery experience. Patients can track their progress in real time, adding a meaningful sense of achievement to their rehabilitation journey. 

To ensure a confident launch, Strolll provided hands-on training to clinical teams across North Tyneside. Therapists have now begun integrating the platform into day-to-day treatment sessions. Early feedback indicates that the augmented reality exercises are improving engagement and supporting more tailored therapeutic interventions. 

The positive reception from Northumbria clinicians reflects a broader NHS ambition to move from analogue practices to evidence-based digital technologies that enhance patient outcomes and streamline clinical processes. Strolll’s rollout shows how digital therapeutics can be incorporated smoothly into existing services when supported by comprehensive training and collaboration. 

As Strolll expands its clinical presence across the UK and the US, its platform is demonstrating strong potential to improve adherence, strengthen clinical outcomes and help patients regain a sense of agency in managing their condition. By embedding innovation at the core of rehabilitation services, Strolll is enabling clinicians to deliver care that is both clinically effective and deeply patient-centred. 

The company’s growth signals a future in which digital therapeutics play a central role in rehabilitation. This shift empowers patients to take an active role in their recovery and provides clinicians with new tools to deliver high-quality, personalised support.